Who invested in TNAX Biopharma?
TNAX Biopharma's investors include Mitsubishi UFJ Capital, Nissay Capital and JAFCO.

Funding summaryUpdated 26 Oct 2026
$4.6Mraised across 1 round since 2019, from 1 source
TNAX Biopharma's investors include Mitsubishi UFJ Capital, Nissay Capital and JAFCO.
TNAX Biopharma has raised $4.6M across 1 round since 2019.
TNAX Biopharma's most recent round was a Series A of $4.6M in Nov 2019.
Its most recent round, $4.6M in Nov 2019, is also its largest on record.
TNAX Biopharma's first round on record, in Nov 2019, was backed by Mitsubishi UFJ Capital, Nissay Capital and JAFCO.
TNAX Biopharma's latest named round is a Series A, in Nov 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.